CapsoVision, Inc. (CV) vs Avita Medical Inc. (RCEL)
A side-by-side comparison of CapsoVision, Inc. and Avita Medical Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CV
CapsoVision, Inc.
$6.50HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
RCEL
Avita Medical Inc.
$12.99HealthcareDelayed quote: Oct 6, 2026, 3:55 PM EDT
Total return — CV vs RCEL
growth of $100 · dividends reinvested · last 1yCV +88.3% (+88.3%/yr)RCEL +150.5% (+150.5%/yr)RCEL compounded faster over this window
CV RCEL
CV vs RCEL: by the numbers
- •CV is the larger company ($325M vs $323M market cap).
- •Both run net losses; RCEL's is the smaller (-56.96% vs -214.74% net margin).
Metrics side by side
Valuation
| Metric | CV | RCEL |
|---|---|---|
| P/S ratio | 23.38 | 4.27 |
| P/B ratio | 24.67 | N/A |
Profitability
| Metric | CV | RCEL |
|---|---|---|
| Gross margin | 50.88% | 81.56% |
| Operating margin | -188.25% | -59.40% |
| Net margin | -214.74% | -56.96% |
| ROE | -226.56% | N/A |
| ROIC | -164.32% | -136.92% |
Growth (annualized)
| Metric | CV | RCEL |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 20.94% |
| Total return CAGR (5Y) | N/A | -5.28% |
Go deeper
Dig into the metrics
CapsoVision ROEAvita Medical ROECapsoVision operating marginAvita Medical operating marginCapsoVision revenue growthAvita Medical revenue growthCapsoVision free cash flowAvita Medical free cash flow
CapsoVision & Avita Medical appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.